Vaccine Development

Biotech company announced results for DNA vaccines project

Published in Hepatitis Weekly, June 27th, 2005

Nature Technology Corporation (NTC) announced positive results from two projects aimed at increasing the effectiveness and productivity of DNA vaccines, respectively.

The results were presented at the American Society of Gene Therapy, in St. Louis, Missouri.

"DNA vaccines represent a bold new way to immunize humans against infectious diseases," said company president, Clague Hodgson, "However, their effectiveness up to the present has been borderline, and the science requires quantum forward leaps in both efficacy and production in order to reach practicality."

NTC scientists Jim Williams and Aaron Carnes headed up the studies at...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2005-06-27)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry